Flow cytometry and cell-based assays at EBF 2026

Nov 17–19, 2026 Barcelona, Spain ~800 attendees Website

7 organizations at EBF 2026 present work in flow cytometry and cell-based assays: 5 CROs and suppliers and 2 drug developers. Between them they bring 20 presentations to the program. Most represented: Sanofi (5 on the program), BioAgilytix (4 on the program), ICON (4 on the program). 7 of them have their own page in this guide. As of Oct 13, 2026.

All 63 organizations at EBF 2026 →

Showing 1–7 of 7 organizations

Organization	EBF 2026 Attendance
Sanofi Paris, France
sanofi.com Pharma Pharmaceutical company developing medicines and vaccines in immunology, rare diseases, neurology and oncology.	Talk Wed Nov 18 12:10–12:30pm Part of Workshop 2: Emerging challenges in the e-environment Rethinking the Discovery Bioanalytical Dataflow using a Bespoke End-to-End Digital Solution Automation & AI Talk Wed Nov 18 12:20–12:40pm Part of Session 14: Rethinking ADA Assessment, Context, Evidence and Evolving Expectations - part 2 The Immunogenicity Nexus: Investigating the Predictive Relationship Between Early-Onset ADA Kinetics in NHP and Human Immune Responses Immunogenicity Talk Thu Nov 19 9–9:20am Part of Session 15: Flow From Raw Data to Insights in Minutes: Development of an Automated Flow Cytometry Data Pipeline for Preclinical Studies Cell-based · Automation & AI Talk Thu Nov 19 2–2:20pm Part of Session 21: Protein MS Tech 2 Generic Hybrid Immunocapture LC-MS/MS Approach for Integrity Assessment of Multispecific Antibodies in Clinical Studies: A Breakthrough Bioanalytical Strategy LC–MS · New modalities Talk Thu Nov 19 2:20–2:40pm Part of Session 21: Protein MS Tech 2 Advanced LC-MS Strategies for In Vivo Bioanalysis of Next-Generation Biotherapeutics: From Method Development to Multi-Therapeutic Area Applications LC–MS · New modalities
BioAgilytix Durham, North Carolina	◇Sponsor
bioagilytix.com Bioanalytical CROsSponsor Bioanalytical CRO specialising in large-molecule PK, immunogenicity, biomarker and cell-based assays, with labs in the US and Europe.	Talk Tue Nov 17 11:50am–12:10pm Part of Session 2: Smarter Workflows: From Implementation to Scientific Confidence Fit-for-Purpose Implementation of a Generic Preclinical PK Assay: Lessons from Platform Transfer and Troubleshooting Ligand binding Talk Tue Nov 17 5:40–6pm Part of Session 9: New technologies and emerging modalities in Bioanalysis: PCR Considering DNA & RNA Extraction for PCR-Based Assay Validations PCR Talk Wed Nov 18 12:20–12:40pm Part of Session 13: BioA Clinic Cross-Platform Evaluation of Total Antibody and Total ADC PK: LBA versus LC-MS New modalities · LC–MS Talk Thu Nov 19 11:10–11:30am Part of Session 20: Pushing the Limits of Sensitivity and Multiplexing in Bioanalysis Responding to Evolving Clinical Needs: A Collaborative Journey to an Ultra-Sensitive PK Assay Ligand binding
ICON Dublin, Ireland	◇Sponsor
iconplc.com Bioanalytical CROsSponsor Global clinical research organization whose laboratories run central lab and regulated bioanalysis services.	Talk Tue Nov 17 4:20–4:40pm Part of Session 9: New technologies and emerging modalities in Bioanalysis: PCR How to validate qPCR assays in rare matrix such as ocular epithelial cells PCR Talk Thu Nov 19 9:20–9:40am Part of Session 15: Flow Implementation and validation of a 25-color immunophenotyping backbone with modular expansion toward 40-color spectral flow cytometry Cell-based Talk Thu Nov 19 9:40–10am Part of Session 16: Protein MS tech 1 The use of multiple signature peptides for quantitative protein bioanalysis by digestion and LC-MS/MS LC–MS Talk Thu Nov 19 2:40–3pm Part of Session 21: Protein MS Tech 2 Analytical aspects of LC-MS/MS-based neutralizing antibody testing LC–MS · Immunogenicity
GSK London, UK
gsk.com Pharma Pharmaceutical company developing vaccines and medicines for infectious diseases, HIV, respiratory and immune-mediated diseases, and oncology.	Talk Tue Nov 17 12:10–12:30pm Part of Session 2: Smarter Workflows: From Implementation to Scientific Confidence Automation Innovations Drive Efficiencies in Flow Cytometry Clinical Sample Testing Automation & AI · Cell-based Talk Tue Nov 17 4:40–5pm Part of Session 8: Pharma CRO Lessons Learned During In-Licensing Talk Wed Nov 18 11:20–11:40am Part of Session 13: BioA Clinic It’s not your assay, it’s us: reappraising the CoU in response to extra-analytical factors Biomarkers Talk Thu Nov 19 9:40–10am Part of Session 15: Flow Operationalising high-parameter flow cytometry for large-scale clinical research Cell-based
Institute Krems Bioanalytics Krems, Austria	◇Sponsor
krems-bioanalytics.com Bioanalytical CROsSponsor Contract research institute of IMC Krems University of Applied Sciences running GxP immunogenicity, PK and cell-based assays for large molecules and vaccines.	Talk Thu Nov 19 10–10:20am Part of Session 15: Flow Towards Harmonization of In Vitro T-Cell Assays: Lessons from the Development of a Naïve CD4+ T-Cell Proliferation Assay Cell-based
KCAS Bio Olathe, Kansas	◇Sponsor
kcasbio.com Bioanalytical CROsSponsor Bioanalytical and biomarker CRO running LC–MS, ligand-binding, flow cytometry and immunogenicity assays for drug developers.	Talk Thu Nov 19 12:30–12:50pm Part of Session 20: Pushing the Limits of Sensitivity and Multiplexing in Bioanalysis Combining versatility and ultrasensitivity with the NULISA technology Biomarkers
Synexa Life Sciences Cape Town, South Africa	◇Sponsor
synexagroup.com Bioanalytical CROsSponsor Bioanalytical and biomarker lab running ligand-binding, flow cytometry and LC–MS assays for drug developers.	Talk Tue Nov 17 11:30–11:50am Part of Session 3: Vaccines When One Calibration Source Must Fit Eight Antigens: Lessons from Convalescent and Vaccinated Serum to Evaluate Vaccine-Induced Antibody Responses Vaccines